Pipeline

Our development programmes represent the potential to improve the well-being of people whose lives are currently limited by rare disease.

BioCryst Pharmaceuticals aims to discover novel, oral small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and an enzyme plays a key role in the biological pathway of the disease.

Our Pipeline